KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Share-based Compensation (2018 - 2025)

Vir Biotechnology's Share-based Compensation history spans 8 years, with the latest figure at $11.2 million for Q4 2025.

  • On a quarterly basis, Share-based Compensation fell 29.26% to $11.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $49.1 million, a 37.45% decrease, with the full-year FY2025 number at $49.1 million, down 37.45% from a year prior.
  • Share-based Compensation hit $11.2 million in Q4 2025 for Vir Biotechnology, down from $11.4 million in the prior quarter.
  • Over the last five years, Share-based Compensation for VIR hit a ceiling of $30.6 million in Q2 2023 and a floor of $11.2 million in Q4 2025.
  • Historically, Share-based Compensation has averaged $21.2 million across 5 years, with a median of $23.4 million in 2021.
  • Biggest five-year swings in Share-based Compensation: surged 421.44% in 2021 and later tumbled 43.97% in 2024.
  • Tracing VIR's Share-based Compensation over 5 years: stood at $24.4 million in 2021, then grew by 2.03% to $24.9 million in 2022, then rose by 13.7% to $28.3 million in 2023, then plummeted by 43.97% to $15.8 million in 2024, then dropped by 29.26% to $11.2 million in 2025.
  • Business Quant data shows Share-based Compensation for VIR at $11.2 million in Q4 2025, $11.4 million in Q3 2025, and $12.5 million in Q2 2025.